For more than a decade, one of the easiest investment decisions was also one of the most profitable: own the United States, particularly its largest technology companies, and allow American exceptionalism to do the rest. The combination of deep capital markets, extraordinary companies, a strong entrepreneurial ecosystem and ultimately the artificial-intelligence boom made the US […]
Tag: China
China spent decades being associated with generic medicines, active pharmaceutical ingredients and low-cost manufacturing. That description is now badly out of date. The more important development for investors is not that China can manufacture drugs cheaply. It is that Chinese companies are increasingly discovering drug candidates, taking them rapidly through early clinical trials and licensing them […]
Market sentiment Looking ahead , the global economic outlook points to slower growth. While consumer spending is expected to remain positive, albeit at a slower pace than last year, some benchmark investors are showing signs of caution. For example, Berkshire Hathaway’s cash position will probably reach $200 billion by the end of the current quarter, […]
For this final update of the year, we take a look at the risks from a global macro perspective, a more detailed evaluation at the currency and equity situation in Asia, and finish with some thoughts on possible entry points for self-made and serious equity investors. Risks and caution in 2024 Will 2024 offer a […]
Exposure to the renminbi and the Chinese economy is to be desired (this century will be dominated economically by Asia/China and exposure to Asia/China is necessary), so the crucial question remains: what is the best way to achieve this.